Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD

Conditions:   End-stage Kidney Disease;   Kidney Disease, Chronic;   Dialysis;   Diabetic;   Non-diabetic;   Kidney Dysfunction;   Kidney Failure;   Hemodialysis Interventions:   Drug: Empagliflozin;   Other: Placebo Sponsors:   University of Utah;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials